...
首页> 外文期刊>Journal of Hainan Medical University >Changes in plaque stability, cell apoptosis and coagulation indexes after patients with unstable angina pectoris accept adjuvant salvianolate therapy
【24h】

Changes in plaque stability, cell apoptosis and coagulation indexes after patients with unstable angina pectoris accept adjuvant salvianolate therapy

机译:不稳定型心绞痛患者接受丹参多酚酸酯类辅助治疗后斑块稳定性,细胞凋亡和凝血指标的变化

获取原文
           

摘要

Objective: To investigate the effect of adjuvant salvianolate therapy on plaque stability, cellapoptosis and coagulation indexes in patients with unstable angina pectoris. Methods: 92patients with unstable angina pectoris treated in our hospital between May 2011 and August2015 were collected, and after the treatment process and auxiliary examination results wereretrospectively analyzed, they were divided into the control group (n=45) who acceptedconventional treatment and the observation group (n=47) who accepted adjuvant salvianolatetreatment. Before and after treatment, diasonograph was used to evaluate the plaque stabilityparameters of two groups of patients; ELISA was used to detect apoptosis-related moleculelevels; immunoturbidimetry was used to detect blood coagulation indexes. Results: Beforetreatment, differences in plaque stability parameters, cell apoptosis molecules and coagulationindexes were not statistically significant between two groups of patients (P0.05). Aftertreatment, the plaque stability parameters plaque thickness, enhanced intensity, rise time andtime to peak of observation group were significantly lower than those of control group (P0.05);serum sFas, sFasL, fibrinogen (Fib), platelet (PLT), and D-Dimer (D-D) levels of observationgroup were significantly lower than those of control group while Bcl-2, prothrombin time (PT)and activated partial thromboplastin time (APTT) levels were significantly higher than those ofcontrol group (P0.05). Conclusions: Adjuvant salvianolate treatment can increase the plaquestability, also inhibit myocardial cell apoptosis and improve the coagulation function in patientswith unstable angina pectoris.
机译:目的:探讨丹参多酚酸酯辅助治疗对不稳定型心绞痛患者斑块稳定性,细胞凋亡和凝血指标的影响。方法:收集2011年5月至2015年8月在我院就诊的92例不稳定型心绞痛患者,回顾性分析治疗过程和辅助检查结果,分为常规治疗的对照组(n = 45)和观察组。 (n = 47)接受了丹参多酚盐辅助治疗。治疗前后用超声检查评估两组患者的斑块稳定性参数。 ELISA用于检测凋亡相关分子水平。免疫比浊法用于检测凝血指标。结果:两组患者治疗前斑块稳定性参数,细胞凋亡分子和凝血指标的差异均无统计学意义(P> 0.05)。治疗后,观察组的斑块稳定性参数,斑块厚度,强度,上升时间和达到峰值的时间均显着低于对照组(P <0.05);血清sFas,sFasL,纤维蛋白原(Fib),血小板(PLT)和观察组D-二聚体(DD)水平明显低于对照组,而Bcl-2,凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)水平明显高于对照组(P <0.05)。结论:丹参多酚酸酯辅助治疗可增加不稳定型心绞痛患者的可噬性,并抑制心肌细胞的凋亡并改善其凝血功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号